|
1.
|
Gustavsson H, Welen K and Damber JE:
Transition of an androgen-dependent human prostate cancer cell line
into an androgen-independent subline is associated with increased
angiogenesis. Prostate. 62:364–373. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Niu Y, Altuwaijri S, Lai KP, et al:
Androgen receptor is a tumor suppressor and proliferator in
prostate cancer. Proc Natl Acad Sci USA. 105:12182–12187. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Lee SO, Dutt SS, Nadiminty N, Pinder E,
Liao H and Gao AC: Development of an androgen-deprivation induced
and androgen suppressed human prostate cancer cell line. Prostate.
67:1293–1300. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Saraon P, Jarvi K and Diamandis EP:
Molecular alterations during progression of prostate cancer to
androgen independence. Clin Chem. 57:1366–1375. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Devlin HL and Mudryj M: Progression of
prostate cancer: multiple pathways to androgen independence. Cancer
Lett. 274:177–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Watson PA, Chen YF, Balbas MD, et al:
Constitutively active androgen receptor splice variants expressed
in castration-resistant prostate cancer require full-length
androgen receptor. Proc Natl Acad Sci USA. 107:16759–16765. 2010.
View Article : Google Scholar
|
|
7.
|
Libertini SJ, Tepper CG, Rodriguez V,
Asmuth DM, Kung HJ and Mudryj M: Evidence for calpain-mediated
androgen receptor cleavage as a mechanism for androgen
independence. Cancer Res. 67:9001–9005. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Cai C and Balk SP: Intratumoral androgen
biosynthesis in prostate cancer pathogenesis and response to
therapy. Endocr Relat Cancer. 18:R175–R182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Chang KH, Li R, Kuri B, et al: A
gain-of-function mutation in DHT synthesis in castration-resistant
prostate cancer. Cell. 154:1074–1084. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Liu T, Mendes DE and Berkman CE: From AR
to c-Met: Androgen deprivation leads to a signaling pathway switch
in prostate cancer cells. Int J Oncol. 43:1125–1130.
2013.PubMed/NCBI
|
|
11.
|
Hendriksen PJ, Dits NF, Kokame K, et al:
Evolution of the androgen receptor pathway during progression of
prostate cancer. Cancer Res. 66:5012–5020. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Lorenzo GD, Bianco R, Tortora G and
Ciardiello F: Involvement of growth factor receptors of the
epidermal growth factor receptor family in prostate cancer
development and progression to androgen independence. Clin Prostate
Cancer. 2:50–57. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Maeda A, Nakashiro K, Hara S, et al:
Inactivation of AR activates HGF/c-Met system in human prostatic
carcinoma cells. Biochem Biophys Res Commun. 347:1158–1165. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Nishida S, Hirohashi Y, Torigoe T, et al:
Prostate cancer stem-like cells/cancer-initiating cells have an
autocrine system of hepatocyte growth factor. Cancer Sci.
104:431–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Storr SJ, Carragher NO, Frame MC, Parr T
and Martin SG: The calpain system and cancer. Nat Rev Cancer.
11:364–374. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Camins A, Verdaguer E, Folch J and Pallas
M: Involvement of calpain activation in neurodegenerative
processes. CNS Drug Rev. 12:135–148. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Lakshmikuttyamma A, Selvakumar P, Kanthan
R, Kanthan SC and Sharma RK: Overexpression of m-calpain in human
colorectal adenocarcinomas. Cancer Epidemiol Biomarkers Prev.
13:1604–1609. 2004.PubMed/NCBI
|
|
18.
|
Kimura Y, Koga H, Araki N, et al: The
involvement of calpain-dependent proteolysis of the tumor
suppressor NF2 (merlin) in schwannomas and meningiomas. Nat Med.
4:915–922. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Mamoune A, Luo JH, Lauffenburger DA and
Wells A: Calpain-2 as a target for limiting prostate cancer
invasion. Cancer Res. 63:4632–4640. 2003.PubMed/NCBI
|
|
20.
|
Rios-Doria J, Day KC, Kuefer R, et al: The
role of calpain in the proteolytic cleavage of E-cadherin in
prostate and mammary epithelial cells. J Biol Chem. 278:1372–1379.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Wang Y, Kreisberg JI, Bedolla RG,
Mikhailova M, deVere White RW and Ghosh PM: A 90 kDa fragment of
filamin A promotes Casodex-induced growth inhibition in
Casodex-resistant androgen receptor positive C4-2 prostate cancer
cells. Oncogene. 26:6061–6070. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Yue J, Huhn S and Shen Z: Complex roles of
filamin-A mediated cytoskeleton network in cancer progression. Cell
Biosci. 3:7–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Bedolla RG, Wang Y, Asuncion A, et al:
Nuclear versus cytoplasmic localization of filamin A in prostate
cancer: immunohistochemical correlation with metastases. Clin
Cancer Res. 15:788–796. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Chen H, Libertini SJ, Wang Y, Kung HJ,
Ghosh P and Mudryj M: ERK regulates calpain 2-induced androgen
receptor proteolysis in CWR22 relapsed prostate tumor cell lines. J
Biol Chem. 285:2368–2374. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Liu T, Wu LY, Fulton MD, Johnson JM and
Berkman CE: Prolonged androgen deprivation leads to downregulation
of androgen receptor and prostate-specific membrane antigen in
prostate cancer cells. Int J Oncol. 41:2087–2092. 2012.PubMed/NCBI
|
|
26.
|
Matroule JY, Carthy CM, Granville DJ,
Jolois O, Hunt DW and Piette J: Mechanism of colon cancer cell
apoptosis mediated by pyropheophorbide-a methylester
photosensitization. Oncogene. 20:4070–4084. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Liu T, Wu LY and Berkman CE:
Prostate-specific membrane antigen-targeted photodynamic therapy
induces rapid cytoskeletal disruption. Cancer Lett. 296:106–112.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Liu T, Toriyabe Y and Berkman CE:
Purification of prostate-specific membrane antigen using
conformational epitope-specific antibody-affinity chromatography.
Protein Expr Purif. 49:251–255. 2006. View Article : Google Scholar
|
|
29.
|
Chan KT, Bennin DA and Huttenlocher A:
Regulation of adhesion dynamics by calpain-mediated proteolysis of
focal adhesion kinase (FAK). J Biol Chem. 285:11418–11426. 2010.
View Article : Google Scholar
|
|
30.
|
Franco SJ, Rodgers MA, Perrin BJ, et al:
Calpain-mediated proteolysis of talin regulates adhesion dynamics.
Nat Cell Biol. 6:977–983. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Kwak HI, Kang H, Dave JM, et al:
Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP
membrane translocation to facilitate endothelial sprout initiation.
Angiogenesis. 15:287–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Jang HS, Lal S and Greenwood JA: Calpain 2
is required for glioblastoma cell invasion: regulation of matrix
metalloproteinase 2. Neurochem Res. 35:1796–1804. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Postovit LM, Dutt P, Dourdin N, et al:
Calpain is required for MMP-2 and u-PA expression in SV40 large
T-antigen-immortalized cells. Biochem Biophys Res Commun.
297:294–301. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Escalante AM, McGrath RT, Karolak MR, Dorr
RT, Lynch RM and Landowski TH: Preventing the autophagic survival
response by inhibition of calpain enhances the cytotoxic activity
of bortezomib in vitro and in vivo. Cancer Chemother Pharmacol.
71:1567–1576. 2013. View Article : Google Scholar : PubMed/NCBI
|
